Date: 2017-02-15
Type of information: Collaboration agreement
Compound: Accu-Chek Guide Link - Bluetooth Low Energy (BLE) enabled blood glucose monitoring meter
Company: Roche (Switzerland) Medtronic (Ireland)
Therapeutic area: Metabolic diseases
Type agreement: collaboration
Action mechanism: medical device.
Disease: diabetes
Details: * On February 15, 2017, Roche announced that it has signed an exclusive partnership agreement with Medtronic. Under the terms of the agreement, Roche will develop a dedicated Bluetooth Low Energy (BLE) enabled blood glucose monitoring meter that will communicate with Medtronic's future BLE enabled insulin pump systems. The new meter will be based on Roche's innovative Accu-Chek Guide platform and will be marketed under the name Accu-Chek Guide Link. The exclusive agreement covers all markets where future BLE enabled pumps will be commercialized.
Financial terms:
Latest news:
